Metformin as an initial adjunct to low-dose liraglutide enhances the weight-decreasing potential of liraglutide in obese polycystic ovary syndrome: Randomized control study.

Exp Ther Med · 2016 · PMC4812364 · PMID 27073422

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

did not reach statistical significanceP=0.051so close (0.05 < p ≤ 0.1)

Fasting glucose decreased by 0.7±1.1 mmol/l in patients treated with COMBO, but only by 0.1±0.6 mmol/l in patients treated with LIRA, although the difference did not reach statistical significance (P=0.051).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.